Cargando…

Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids

Background: Selective progesterone receptor modulator ulipristal acetate (UPA) is a drug used in management of symptomatic myomas. It was observed that the response to UPA treatment in uterine myomas varied amongst patients. An attempt was thus made at establishing predictive factors conducive to be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szydłowska, Iwona, Marciniak, Aleksandra, Nawrocka-Rutkowska, Jolanta, Rył, Aleksandra, Starczewski, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037608/ https://www.ncbi.nlm.nih.gov/pubmed/32012826 http://dx.doi.org/10.3390/ijerph17030798

Ejemplares similares

Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

Markers of Cellular Proliferation, Apoptosis, Estrogen/Progesterone Receptor Expression and Fibrosis in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

Dietary Natural Compounds and Vitamins as Potential Cofactors in Uterine Fibroids Growth and Development
por: Szydłowska, Iwona, et al.
Publicado: (2022)

Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate
por: Rabe, Thomas, et al.
Publicado: (2018)

Lymphangioleiomyomatosis with Tuberous Sclerosis Complex—A Case Study
por: Marciniak, Aleksandra, et al.
Publicado: (2023)

Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
por: Rabe, Thomas, et al.
Publicado: (2018)

Evaluation of the Diagnostic Accuracy of the Interview and Physical Examination in the Diagnosis of Endometriosis as the Cause of Chronic Pelvic Pain
por: Nawrocka-Rutkowska, Jolanta, et al.
Publicado: (2021)

Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids
por: Biglia, Nicoletta, et al.
Publicado: (2014)

Ulipristal acetate as a treatment option for uterine fibroids
por: Piecak, Karolina, et al.
Publicado: (2017)

Assessment of the Parameters of Oxidative Stress Depending on the Metabolic and Anthropometric Status Indicators in Women with PCOS
por: Nawrocka-Rutkowska, Jolanta, et al.
Publicado: (2022)

Successful Pregnancy after Treatment with Ulipristal Acetate for Uterine Fibroids
por: Monleón, Javier, et al.
Publicado: (2014)

Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
por: Trefoux Bourdet, Alice, et al.
Publicado: (2015)

Safety after extended repeated use of ulipristal acetate for uterine fibroids
por: Fauser, Bart C. J. M., et al.
Publicado: (2017)

Economic impact of ulipristal acetate on surgical procedures for uterine fibroids in France
por: Fernandez, Hervé, et al.
Publicado: (2017)

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids
por: Middelkoop, Mei-An, et al.
Publicado: (2022)

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
por: Kolterud, Åsa, et al.
Publicado: (2022)

Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis
por: Geale, Kirk, et al.
Publicado: (2017)

Ulipristal acetate, a progesterone receptor modulator for emergency contraception
por: Jadav, Shilpa P., et al.
Publicado: (2012)

Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
por: Ekanem, Emmanuel, et al.
Publicado: (2020)

The effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up
por: Woźniak, Sławomir, et al.
Publicado: (2014)

Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur?
por: Odejinmi, Funlayo, et al.
Publicado: (2017)

The use of a short course of Ulipristal Acetate for acute abnormal uterine bleeding in women without uterine fibroids
por: Lambrecht, I, et al.
Publicado: (2023)

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management
por: Tsoi, Bernice, et al.
Publicado: (2015)

Phase III long‐term study to evaluate the efficacy and safety of ulipristal acetate in Japanese patients with uterine fibroids
por: Osuga, Yutaka, et al.
Publicado: (2021)

Safety and efficacy of two repeated cycles of ulipristal acetate in the management of symptomatic uterine fibroid among Indian women
por: Jha, Sangam, et al.
Publicado: (2021)

Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium
por: Whitaker, L.H.R., et al.
Publicado: (2017)

SUN-019 The Selective Progesterone Receptor Modulator Ulipristal Acetate Blocks Glucocorticoid Receptor Transactivation
por: Smalls, Benjamin, et al.
Publicado: (2019)

The Role of Oxidative Stress in the Risk of Cardiovascular Disease and Identification of Risk Factors Using AIP and Castelli Atherogenicity Indicators in Patients with PCOS
por: Nawrocka-Rutkowska, Jolanta, et al.
Publicado: (2022)

Ulipristal Acetate Efficacy in a Patient with Symptomatic Fibroid and Concomitant Pulmonary Embolism
por: von Wunster, S., et al.
Publicado: (2020)

Ulipristal acetate before in vitro fertilization: efficacy in infertile women with submucous fibroids
por: Morgante, Giuseppe, et al.
Publicado: (2020)

Ulipristal acetate for Japanese women with symptomatic uterine fibroids: A double‐blind, randomized, phase II dose‐finding study
por: Irahara, Minoru, et al.
Publicado: (2019)

Ulipristal Acetate in Adenomyosis
por: Gonçalves-Henriques, Manuel, et al.
Publicado: (2022)

Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve – an observational study
por: Czuczwar, Piotr, et al.
Publicado: (2018)

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
por: Gatti, Milo, et al.
Publicado: (2020)

Expulsion of a uterine myoma in a patient treated with ulipristal acetate
por: Chantraine, Frederic, et al.
Publicado: (2015)

Suspension of ulipristal acetate for uterine fibroids during ongoing EMA’s review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!
por: Rozenberg, Serge, et al.
Publicado: (2020)

A Properly Balanced Reduction Diet and/or Supplementation Solve the Problem with the Deficiency of These Vitamins Soluble in Water in Patients with PCOS
por: Szczuko, Małgorzata, et al.
Publicado: (2021)

Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports
por: Santoro, Angela, et al.
Publicado: (2018)

Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids(†)
por: Ali, Mohamed, et al.
Publicado: (2017)

Effect of a Selective Progesterone Receptor Modulator on Induction of Apoptosis in Uterine Fibroids In Vivo
por: Horak, Petr, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_585idk2fch5dl8ctd2kf33smh8